Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vascular endothelial dysfunction: does tetrahydrobiopterin play a role?

Z S Katusic1

  • 1Department of Anesthesiology, Mayo Clinic, Rochester, Minnesota 55905, USA. katusic.zvonmir@mayo.edu

American Journal of Physiology. Heart and Circulatory Physiology
|August 22, 2001
PubMed
Summary

Tetrahydrobiopterin (BH4) is vital for nitric oxide synthase (NOS) function. Low BH4 levels impair nitric oxide production, contributing to vascular endothelial dysfunction, but supplementation shows promise for improving vascular health.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetic deficiency of heme oxygenase-1 impairs functionality and form of an arteriovenous fistula in the mouse.

Kidney international·2008
Same author

Gene delivery to the vasculature mediated by low-titre adeno-associated virus serotypes 1 and 5.

The journal of gene medicine·2007
Same author

EPO tecting the endothelium.

British journal of pharmacology·2007
Same author

A direct mechanical method for accurate and efficient adenoviral vector delivery to tissues.

Gene therapy·2003
Same author

Hypercholesterolemia impairs endothelium-dependent relaxations in common carotid arteries of apolipoprotein e-deficient mice.

Stroke·2001
Same author

Protective effect of heme oxygenase-1 gene transfer against oxyhemoglobin-induced endothelial dysfunction.

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism·2001

Area of Science:

  • Biochemistry
  • Vascular Biology
  • Pharmacology

Background:

  • Tetrahydrobiopterin (BH4) is a critical cofactor for nitric oxide synthase (NOS).
  • Its precise role in regulating NOS activity and its implications in vascular dysfunction are under investigation.
  • Suboptimal BH4 levels can lead to NOS uncoupling, producing superoxide instead of nitric oxide.

Purpose of the Study:

  • To review the role of tetrahydrobiopterin in the pathogenesis of vascular endothelial dysfunction.
  • To discuss the mechanisms behind the beneficial vascular effects of tetrahydrobiopterin.
  • To explore BH4's potential as a therapeutic target for vascular diseases.

Main Methods:

  • Literature review of existing evidence on tetrahydrobiopterin and NOS.

Related Experiment Videos

  • Analysis of studies investigating BH4 supplementation in experimental animals and humans.
  • Examination of the interplay between oxidative stress, BH4 metabolism, and endothelial function.

    • Main Results:

    • Accelerated BH4 catabolism in oxidative stress contributes to endothelial dysfunction in conditions like hypertension and diabetes.
    • Tetrahydrobiopterin supplementation demonstrates beneficial effects on endothelial function.
    • Antioxidants like vitamin C may exert vascular benefits by increasing intracellular BH4 concentrations.

    Conclusions:

    • Tetrahydrobiopterin plays a significant role in maintaining vascular endothelial function.
    • Dysregulation of BH4 metabolism is implicated in the development of vascular diseases.
    • BH4 supplementation and strategies to increase its levels represent promising therapeutic avenues for endothelial dysfunction.